http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112138157-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0071 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 |
| filingDate | 2020-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-18^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-18^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112138157-B |
| titleOfInvention | Optically controlled granulocyte biological agent and preparation and application thereof |
| abstract | The invention relates to an optically controlled granulocyte biological agent, and a preparation method and application thereof. The optically controlled granulocyte biological agent comprises granulocytes and a photosensitizer loaded in the granulocytes. Compared with the prior art, the invention constructs the light-controlled granulocyte (NE) capable of generating ROS under the excitation of light by loading photosensitizer in the granulocyte by an engineering means P ) The optical control granulocyte biological agent can be used for clinical tumor treatment, namely, the generation of a photosensitizer ROS in the optical control granulocyte is regulated and controlled through remote control of light, the local concentration of the ROS is improved, and the ROS killing and enhancing effect of the optical control granulocyte on tumors is realized. |
| priorityDate | 2020-09-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 49 of 49.